Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Invesco Mortgage Capital
IVR
$794M
| $8.08M | ﹤0.01% |
634,750
+41,349
| +7% | +$505K |
|
2402
BioXcel Therapeutics
BTAI
$28.4M
| $8.05M | ﹤0.01% |
23,437
+1,216
| +5% | +$294K |
|
2403
Crescent Energy
CRGY
$4.02B
| $8.05M | ﹤0.01% |
671,365
+111,118
| +20% | +$1.53M |
|
|
OLP
2404
One Liberty Properties
OLP
$515M
| $8.03M | ﹤0.01% |
361,185
+12,385
| +4% | +$284K |
|
2405
Forrester Research
FORR
$224M
| $8.02M | ﹤0.01% |
224,337
+7,292
| +3% | +$267K |
|
|
ESPR
2406
DELISTED
Esperion Therapeutics
ESPR
| $7.97M | ﹤0.01% |
1,279,924
+152,344
| +14% | +$1.09M |
|
2407
SI-BONE Inc
SIBN
$850M
| $7.95M | ﹤0.01% |
584,483
+15,959
| +3% | +$233K |
|
|
NVTA
2408
DELISTED
Invitae Corporation
NVTA
| $7.94M | ﹤0.01% |
4,271,016
+242,454
| +6% | +$592K |
|
2409
Century Aluminum
CENX
$5.19B
| $7.93M | ﹤0.01% |
969,251
-6,225
| -0.6% | -$47K |
|
2410
Excelerate Energy
EE
$1.13B
| $7.93M | ﹤0.01% |
316,476
+9,296
| +3% | +$244K |
|
2411
Ezcorp Inc
EZPW
$1.68B
| $7.92M | ﹤0.01% |
972,022
+24,922
| +3% | +$222K |
|
2412
Compañía de Minas Buenaventura
BVN
$8.76B
| $7.91M | ﹤0.01% |
1,066,269
+114,944
| +12% | +$851K |
|
2413
Vital Farms
VITL
$495M
| $7.91M | ﹤0.01% |
529,959
+31,381
| +6% | +$433K |
|
2414
Hingham Institution for Saving
HIFS
$652M
| $7.9M | ﹤0.01% |
28,644
+1,352
| +5% | +$356K |
|
|
SRNE
2415
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $7.89M | ﹤0.01% |
8,905,936
+1,797,652
| +25% | +$2.38M |
|
2416
Mitek Systems
MITK
$815M
| $7.88M | ﹤0.01% |
813,351
+29,520
| +4% | +$311K |
|
2417
OneSpan
OSPN
$617M
| $7.83M | ﹤0.01% |
700,178
+11,523
| +2% | +$132K |
|
|
SGMO
2418
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $7.83M | ﹤0.01% |
2,494,871
+112,436
| +5% | +$436K |
|
|
STKL
2419
DELISTED
SunOpta
STKL
| $7.82M | ﹤0.01% |
926,855
+34,214
| +4% | +$323K |
|
2420
Amalgamated Financial
AMAL
$1.48B
| $7.8M | ﹤0.01% |
338,600
+49,125
| +17% | +$1.19M |
|
2421
Target Hospitality
TH
$1.64B
| $7.8M | ﹤0.01% |
514,958
+8,419
| +2% | +$113K |
|
2422
Mirum Pharmaceuticals
MIRM
$6.01B
| $7.79M | ﹤0.01% |
399,682
+20,180
| +5% | +$399K |
|
2423
Nektar Therapeutics
NKTR
$2.54B
| $7.78M | ﹤0.01% |
229,581
+7,848
| +4% | +$380K |
|
2424
Vanda Pharmaceuticals
VNDA
$299M
| $7.78M | ﹤0.01% |
1,052,590
+26,077
| +3% | +$254K |
|
2425
Dutch Bros
BROS
$8.95B
| $7.77M | ﹤0.01% |
275,548
+40,493
| +17% | +$1.34M |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.